Ira Yunita, Afif Nurul Hidayati, Muhammad Yulianto Listiawan, Evy Ervianti, Budi Utomo, Damayanti, Sylvia Anggraeni, Menul Ayu Umborowati, Cita Rosita Sigit Prakoeswa
Ira Yunita1, Afif Nurul Hidayati1, Muhammad Yulianto Listiawan1, Evy Ervianti1, Budi Utomo2, Damayanti1, Sylvia Anggraeni1, Menul Ayu Umborowati1, Cita Rosita Sigit Prakoeswa1*
1Department of Dermatology and Venereology, Universitas Airlangga/ Dr. Soetomo General Academic Teaching Hospital, Universitas Airlangga Teaching Hospital, Surabaya, Indonesia.
2Department of Public Health Sciences, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
Volume - 16,
Issue - 5,
Year - 2023
Background: Psoriasis is a chronic inflammatory skin disease that involves several factors, genetic, immunity defects, hormones, and environmental factors. Psoriasis vulgaris is often characterized by a thick, erythematous, well-defined, rough, layered, silvery white plaque. Methotrexate is a first-line systemic therapy in the management of psoriasis vulgaris. This drug effective to reduce the severity of the disease by at least 50% in more than 75% of patients. Unfortunately, methotrexate also has the potential to cause adverse effects, this drug is considered one of the main causes of increased liver enzymes in psoriasis patients for several years so special consideration is needed when prescribing methotrexate to patients. Therefore, periodic evaluation during the use of this drug is needed to find out the side effects that can be caused. Purpose: The aim was to to evaluate PASI, SGOT and SGPT score of psoriasis vulgaris patients who received methotrexate therapy at Dermatology and Venerology Outpatient and Inpatient Clinic Dr. Soetomo General Academic Hospital Surabaya. Methods: This was a observational analytical study with retrospective data through one shot case study pre-experimental study approach, but was conducted pre and post treatment that aimed to evaluate PASI, SGOT and SGPT score of psoriasis vulgaris patients who received methotrexate therapy at Dermatology and Venerology Outpatient and Inpatient Clinic Dr. Soetomo General Academic Hospital Surabaya for the period January 2018-December 2020. Results: The results of this study were 51 psoriasis patients who received methotrexate that include in inclusion criteria. The number of male patients was more than women, 30(58,8%) for men and 21(41.2%) for women. There was a statistically significant difference in the reduction in PASI score of psoriasis vulgaris patients before and after methotrexate therapy (p = 0.001). However, the results of statistical analysis SGOT score of psoriasis vulgaris patients before methotrexate therapy were no different than after receiving methotrexate therapy (p = 0.286). In contrast, the results of statistical analysis SGPT score of psoriasis vulgaris patients after receiving methotrexate therapy increased significantly compared to before receiving methotrexate therapy (p = 0.001). Conclusion: there was significant decrease in PASI scores and significant increase in SGPT scores before and after receiving methorexate therapy. However, for SGOT scores statistically there was no significant difference before and after receiving methorexate therapy.
Cite this article:
Ira Yunita, Afif Nurul Hidayati, Muhammad Yulianto Listiawan, Evy Ervianti, Budi Utomo, Damayanti, Sylvia Anggraeni, Menul Ayu Umborowati, Cita Rosita Sigit Prakoeswa. Evaluation of Efficacy and Side Effects of Impairement Liver Function in Psoriasis Vulgaris Patients Treated with Methotrexate in Dr. Soetomo General Academic Hospital Surabaya: A Retrospective Study. Research Journal of Pharmacy and Technology 2023; 16(5):2301-5. doi: 10.52711/0974-360X.2023.00378
Ira Yunita, Afif Nurul Hidayati, Muhammad Yulianto Listiawan, Evy Ervianti, Budi Utomo, Damayanti, Sylvia Anggraeni, Menul Ayu Umborowati, Cita Rosita Sigit Prakoeswa. Evaluation of Efficacy and Side Effects of Impairement Liver Function in Psoriasis Vulgaris Patients Treated with Methotrexate in Dr. Soetomo General Academic Hospital Surabaya: A Retrospective Study. Research Journal of Pharmacy and Technology 2023; 16(5):2301-5. doi: 10.52711/0974-360X.2023.00378 Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-5-37
1. Adiguna MS, Rusyati LMM, Sudarsa PSS. Correlation of plasma vitamin d receptors with the severity of psoriasis vulgaris. Bali Medical Journal. 2020 9(3): 668–671. DOI: 10.15562/bmj.v9i3.2013
2. Meher C, Iswara R LK, Roesyanto-Mahadi Irma D. The correlation TNF-α gene promoter region -238g, -308g, -857, and -1031 polymorphism with psoriasis vulgaris. Bali Medical Journal. 2021; 10(1): 126-131.
3. Gudjonsson JE. & Elder JT. 2019. Psoriasis. In Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, et al., editors. Fitzpatrick’s Dermatology. 9th ed. New York: McGraw-Hill Education. 457–97. Accessed September 07, 2022. https://accessmedicine.mhmedical.com/content.aspx?bookid=2570§ionid=210417798
4. Jameel Ahmed Mulla, Sarasija Suresh, Imtiyaz Ahmed Khazi. Formulation, Characterization and in vitro Evaluation of Methotrexate Solid Lipid Nanoparticles. Research J. Pharm. and Tech. 2 (4): Oct.-Dec. 2009; Page 685-689
5. Kotadiya RM, Patel VA, Patel HV. Factorial Design Based Formulation and Characterization of the Controlled Release Methotrexate Beads. Research J. Pharm. and Tech. 2(3): July-Sept. 2009, 592-596.
6. Karishma Kapoor, Vinay Pandit, Upendra Nagaich. Topical Methotrexate Cubosomes in Treatment of Rheumatoid Arthritis: Ex-Vivo and In-Vivo Studies. Research J. Pharm. and Tech. 2021; 14(2):991-996. doi: 10.5958/0974-360X.2021.00177.3
7. Fiore M. Leone S. Maraolo AE. Berti E. Damiani G. Liver illness and psoriatic patients. Biomed Res Int. 2018; 2018:3140983. Published 2018 Feb 6. doi:10.1155/2018/3140983
8. Vaibhav Tripathi, Adeep Kujur, Manmeet Singh Saluja. Hepatoprotective Activity of Stem Bark of Nyctanthes arbor-tristis linn. Research Journal of Pharmacology and Pharmacodynamics. 2015; 7(3): 124-128. doi: 10.5958/2321-5836.2015.00023.3
9. P Natarajan, A Thanga Thirupathi, T Raja Sekharan, AS William Arputha Sundar, R Arivukkarasu, M Ganesan. Hepatoprotective effect of Glinus oppositifolius Linn. Research J. Pharmacology and Pharmacodynamics. 2010; 2(4): 289-292.
10. Coimbra S. Santos-Silva A. Biomarkers of psoriasis severity and therapy monitoring. World J Dermatol. 2014; 3(2):15-27. https://dx.doi.org/10.5314/wjd.v3.i2.15
11. Colombo D. Cassano N. Bellia G. Vena GA. Gender medicine and psoriasis. World J Dermatol. 2014; 3(3):36-44. https://dx.doi.org/10.5314/wjd.v3.i3.36
12. Cabello Zurita C. Grau Pérez M. Hernández Fernández CP et al. Effectiveness and safety of Methotrexate in psoriasis: an eight-year experience with 218 patients. J Dermatolog Treat. 2017;28(5):401-405. doi:10.1080/09546634.2016.1273469
13. Chan IL. Cohen S. da Cunha MG. Maluf LC. Characteristics and management of Asian skin. Int J Dermatol. 2019;58(2):131-143. doi:10.1111/ijd.14153
14. Sandhya Lekshmi. S, Remya Antony, Neeraj Sidharthan, Gireesh Kammath, Anila. K. N. Methotrexate Induced Lung Toxicity- A Case Report. Research J. Pharm. and Tech 2017; 10(10):3458-3460. doi: 10.5958/0974-360X.2017.00617.5
15. Chandrasekhara Rao, S. Vidyadhara, K.V. Ragahavendrarao, K. Vanitha Prakassh, B. Umashankar Srilatha. Formulation and Evaluation of Sustained Release Methotrexate Microcapsules. Research J. Pharm. and Tech. 4(12): Dec. 2011; Page 1861-1864.
16. Menter A. Gelfand JM. Connor C et al. Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies. J Am Acad Dermatol. 2020;82(6):1445-1486. doi:10.1016/j.jaad.2020.02.044
17. B Suneetha, K V S R G Prasad, P.Deepthi Nishanthi2, B R Soumya, B Sampath Kumar. Hepatoprotective and Antioxidant Activity of Methanolic Extract of Actinodaphne madraspatana against Carbon tetrachloride Induced Hepatotoxicity. Res. J. Pharmacognosy & Phytochem. 2014; 6(4): 176-180.
18. Reza A. Rachmawati B. Perbedaan kadar sgot dan sgpt antara subyek dengan dan tanpa diabetes mellitus. Jurnal Kedokteran Diponegoro (Diponegoro Medical Journal) [Online]. 2017; 6(2):158-166. doi: 10.14710/dmj.v6i2.18530.
19. Raaby L. Zachariae C. Østensen M et al. Methotrexate use and monitoring in patients with psoriasis: a consensus report based on a Danish expert meeting. Acta Derm Venereol. 2017;97(4):426-432. doi: 10.2340/00015555-2599
20. Hidayat FA, Nababan KA, Roesyanto ID. Relationship between serum IgE levels and psoriasis area and severity index (PASI) score in psoriasis vulgaris. Bali Medical Journal. 2021; 10(3): 1020–1025. DOI: 10.15562/bmj.v10i3.2861
21. Marpaung SC, Jusuf NK, Putra IB. Comparison of brain-derived neurotrophic factor (BDNF) serum level in inflammatory and non-inflammatory acne vulgaris. Bali Medical Journal. 2021; 10(2): 659-662.
22. Hendaria MP, Hidayati AN, Evy Ervianti, Muhammad Yulianto Listiawan, Damayanti, Irmadita Citrashanty, Sylvia Anggraeni, Menul Ayu Umborowati, Budi Utomo, Cita Rosita Sigit Prakoeswa. Clinical improvement of patients with moderate-to-severe psoriasis treated with methotrexate at Dr. Soetomo General Hospital, Surabaya, Indonesia. Bali Medical Journal. 2022; 11(1): 328–333. DOI: 10.15562/bmj.v11i1.3417
23. Sasmito EH, Zulkarnain I, Listiawan MY, Indramaya DM, Astari L, Utomo B. Combination effect of methotrexate with Narrowband Ultraviolet B (NB-UVB) phototherapy in psoriasis vulgaris patients in dermatology and venereology outpatient clinic Dr. Soetomo General Academic Hospital, Surabaya, Indonesia. Bali Medical Journal. 2022; 11(1): 116-121. DOI: 10.15562/bmj.v11i1.3071